Loading...
CNBX Pharmaceuticals Inc.
CNBX•PNK
Healthcare
Biotechnology
$0.001
$0.00(25.00%)
CNBX Pharmaceuticals Inc. (CNBX) Financial Performance & Income Statement Overview
Review CNBX Pharmaceuticals Inc.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
-68.29%
↓ 68.29%
Operating Income Growth
37.39%
↑ 37.39%
Net Income Growth
81.26%
↑ 81.26%
Operating Cash Flow Growth
-117.09%
↓ 117.09%
Operating Margin
-1743.83%
↓ 1743.83%
Gross Margin
100.00%
↑ 100.00%
Net Profit Margin
-1681.02%
↓ 1681.02%
ROE
11.79%
↑ 11.79%
ROIC
11.92%
↑ 11.92%
CNBX Pharmaceuticals Inc. (CNBX) Income Statement & Financial Overview
Review CNBX Pharmaceuticals Inc.'s (CNBX) income statement with detailed quarterly and annual figures.
| Metric | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
|---|---|---|---|---|
| Cash & Cash Equivalents | $45675.00 | $17339.00 | $26416.00 | $73406.00 |
| Short Term Investments | $0.00 | $0.00 | $0.00 | $0.00 |
| Cash & Short Term Investments | $45675.00 | $17339.00 | $26416.00 | $73406.00 |
| Net Receivables | $4985.00 | $4969.00 | $4967.00 | $0.00 |
| Inventory | $0.00 | $0.00 | $0.00 | $0.00 |
| Other Current Assets | $0.00 | $0.00 | $0.00 | $6621.00 |
| Total Current Assets | $50660.00 | $22308.00 | $31383.00 | $80027.00 |
| Property Plant & Equipment (Net) | $0.00 | $0.00 | $0.00 | $0.00 |
| Goodwill | $0.00 | $0.00 | $0.00 | $0.00 |
| Intangible Assets | $0.00 | $0.00 | $0.00 | $0.00 |
| Goodwill & Intangible Assets | $0.00 | $0.00 | $0.00 | $0.00 |
| Long Term Investments | $0.00 | $0.00 | $0.00 | $0.00 |
| Tax Assets | $0.00 | $0.00 | $0.00 | $0.00 |
| Other Non-Current Assets | $0.00 | $0.00 | $0.00 | $0.00 |
| Total Non-Current Assets | $0.00 | $0.00 | $0.00 | $0.00 |
| Total Assets | $50660.00 | $22308.00 | $31383.00 | $80027.00 |
| Account Payables | $62943.00 | $51992.00 | $40841.00 | $189820.00 |
| Short Term Debt | $0.00 | $0.00 | $1.30M | $1.29M |
| Tax Payables | $0.00 | $0.00 | $0.00 | $0.00 |
| Deferred Revenue | $0.00 | $0.00 | $0.00 | $0.00 |
| Other Current Liabilities | $2.56M | $2.48M | $1.18M | $1.05M |
| Total Current Liabilities | $2.62M | $2.54M | $2.51M | $2.53M |
| Long Term Debt | $0.00 | $0.00 | $0.00 | $0.00 |
| Deferred Revenue Non-Current | $0.00 | $0.00 | $0.00 | $0.00 |
| Deferred Tax Liabilities Non-Current | $0.00 | $0.00 | $0.00 | $0.00 |
| Other Non-Current Liabilities | $0.00 | $0.00 | $0.00 | $0.00 |
| Total Non-Current Liabilities | $0.00 | $0.00 | $0.00 | $0.00 |
| Capital Lease Obligations | $0.00 | $0.00 | $0.00 | $0.00 |
| Total Liabilities | $2.62M | $2.54M | $2.51M | $2.53M |
| Preferred Stock | $0.00 | $0.00 | $0.00 | $0.00 |
| Common Stock | $3386.00 | $3111.00 | $3111.00 | $3111.00 |
| Retained Earnings | -$25.06M | -$24.99M | -$24.95M | -$24.89M |
| Accumulated Other Comprehensive Income/Loss | $0.00 | $0.00 | $0.00 | $0.00 |
| Total Stockholders Equity | -$2.57M | -$2.51M | -$2.48M | -$2.45M |
| Total Equity | -$2.57M | -$2.51M | -$2.48M | -$2.45M |
| Total Liabilities & Stockholders Equity | $50660.00 | $22308.00 | $31383.00 | $80027.00 |
| Total Investments | $0.00 | $0.00 | $0.00 | $0.00 |
| Total Debt | $1.40M | $1.33M | $1.30M | $1.29M |
| Net Debt | $1.35M | -$17339.00 | $1.27M | $1.22M |
CNBX Pharmaceuticals Inc. (CNBX) Balance Sheet Analysis
CNBX Pharmaceuticals Inc. (CNBX) manages its money wisely, with plenty of -117.09% and 81.26% to cover its bills. The company’s long-term debts are N/A, balanced by steady -1681.02%. Shareholders’ stake in the business has shrunk. Overall, the numbers show a cautious position, giving it room to invest, expand, or adapt. For investors, this paints a risky picture for the future.Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan